Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NewAge was a U.S.-based publicly traded consumer products company focused on healthy beverages, nutritional supplements, personal care, and wellness products rather than prescription therapeutics. The company originally operated as New Age Beverages Corporation and later rebranded to NewAge, expanding into direct-to-consumer and social selling after acquisitions including Morinda and ARIIX. Its portfolio included functional beverages and wellness brands such as Tahitian Noni, LIMU, ARIIX, and related nutrition products sold across multiple international markets. In August 2022, NewAge and certain subsidiaries filed for Chapter 11 bankruptcy, and the operating business assets were subsequently sold in bankruptcy proceedings. As a result, NewAge should not be considered an active biotech, pharma, or healthcare R&D company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NewAge.